Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

SELL
$25.06 - $34.09 $10,024 - $13,636
-400 Reduced 2.17%
18,017 $511,000
Q1 2022

Apr 27, 2022

SELL
$44.58 - $52.6 $4,458 - $5,260
-100 Reduced 0.54%
18,417 $911,000
Q4 2021

Jan 24, 2022

BUY
$45.82 - $56.9 $4,582 - $5,690
100 Added 0.54%
18,517 $943,000
Q1 2021

Apr 22, 2021

SELL
$40.32 - $50.97 $20,160 - $25,485
-500 Reduced 2.64%
18,417 $769,000
Q3 2020

Nov 06, 2020

SELL
$37.02 - $51.28 $7,404 - $10,256
-200 Reduced 1.05%
18,917 $0
Q2 2020

Jul 21, 2020

SELL
$43.24 - $55.02 $8,258 - $10,508
-191 Reduced 0.99%
19,117 $917,000
Q4 2019

Jan 24, 2020

BUY
$54.32 - $64.31 $523,155 - $619,369
9,631 Added 99.52%
19,308 $1.16 Million
Q1 2019

May 07, 2019

BUY
$38.66 - $51.82 $8,041 - $10,778
208 Added 2.2%
9,677 $489,000
Q4 2018

Jan 28, 2019

BUY
$36.72 - $67.73 $1,578 - $2,912
43 Added 0.46%
9,469 $382,000
Q3 2018

Nov 02, 2018

BUY
$66.65 - $83.86 $47,388 - $59,624
711 Added 8.16%
9,426 $654,000
Q2 2018

Aug 01, 2018

SELL
$51.25 - $76.62 $61,500 - $91,944
-1,200 Reduced 12.1%
8,715 $659,000
Q1 2018

May 01, 2018

BUY
$52.16 - $66.86 $62,591 - $80,232
1,200 Added 13.77%
9,915 $522,000
Q4 2017

Feb 12, 2018

BUY
$49.6 - $60.87 $7,836 - $9,617
158 Added 1.85%
8,715 $466,000
Q3 2017

Oct 30, 2017

SELL
$46.62 - $60.36 $102,564 - $132,792
-2,200 Reduced 20.45%
8,557 $510,000
Q2 2017

Aug 11, 2017

BUY
N/A
10,757
10,757 $849,000

Others Institutions Holding EGRX

About EAGLE PHARMACEUTICALS, INC.


  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.81M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track New York State Teachers Retirement System Portfolio

Follow New York State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on New York State Teachers Retirement System with notifications on news.